"
Template:SupbiotechparisEn
From 2009.igem.org
(Difference between revisions)
Enguerrand (Talk | contribs) |
Enguerrand (Talk | contribs) |
||
| Line 32: | Line 32: | ||
<div id="menuhaut"> | <div id="menuhaut"> | ||
{| style="background-color: transparent;" cellpadding="3" cellspacing="20" align="center" | {| style="background-color: transparent;" cellpadding="3" cellspacing="20" align="center" | ||
| - | !align="center"|[[Team:SupBiotech-Paris/HomeEn|Home]] | + | !align="center"|[[Team:SupBiotech-Paris/HomeEn#drapeau|Home]] |
| - | !align="center"|[[Team:SupBiotech-Paris/Team|Team]] | + | !align="center"|[[Team:SupBiotech-Paris/Team#drapeau|Team]] |
| - | !align="center"|[[Team:SupBiotech-Paris/Project Management|Project Management]] | + | !align="center"|[[Team:SupBiotech-Paris/Project Management#drapeau|Project Management]] |
| - | !align="center"|[[Team:SupBiotech-Paris/Media|Media]] | + | !align="center"|[[Team:SupBiotech-Paris/Media#drapeau|Media]] |
| - | !align="center"|[[Team:SupBiotech-Paris/Acknowledgement|Acknowledgement]] | + | !align="center"|[[Team:SupBiotech-Paris/Acknowledgement#drapeau|Acknowledgement]] |
|} | |} | ||
</div> | </div> | ||
Revision as of 22:42, 22 September 2009
Project
Introduction Current therapies Gene therapies DVS Concept Introduction Tissue Vector Cell Vector Apoptotic plasmid Conclusion Implementation Tissue targeting Cell targeting Cancer Modelisation Conclusion
Ressources
Biobricks Material & Method Bibliography
Ethic & Safety
Synthetic Biology Our project Safety
